logo
  Join        Login             Stock Quote

Rising Concerns On Economy Pushes The US Market To A New Low; Industrial Stocks Loses

 August 02, 2011 05:31 PM
 


For the seventh successive day, the US market closed the day's trading on a negative note, its longest losing streak since 2008. Despite the passage of the much awaited debt-ceiling bill in the Senate, investors remained pessimistic following more signs of weaknesses in the country's economy and poor earnings by several big companies.

The Dow Jones industrial average slumped 2.19 percent or 265.87 points to close at 11,866.62. The Nasdaq Stock Market Inc. composite index was down 2.75 percent or 75.37 points to finish at 2,699.24. The Standard & Poor's 500 index fell 2.56 percent or 32.89 points to end the day at 1,254.05, to record its lowest point of the year. Among other major indices, the New York Stock Exchange composite index lost 2.60 percent or 208.95 points to close at 7,831.98. The American Stock Exchange composite index slipped 1 percent or 23.99 points to finish the day at 2,367.76.

[Related -Boost Your Dividend Yield]

Hot Stocks of the Day: INPH, AKRX, GOOG, RPXC, MD

Interphase Corp. (Nasdaq: INPH) adopts a new Shareholders Right Agreement, under which the shareholders as of on August 9, 2011 will receive a distribution of rights to purchase additional shares of the company's common stock. Shares gained 21.80 percent or $1.04 to close at $5.81.

Akorn, Inc. (Nasdaq: AKRX) agreed to buy a minority stake in eye drug maker Aciex Therapeutics. Shares of Akorn added 6.22 percent or 45 cents to end at $7.68.

[Related -Google Inc (GOOG): Why Nest Labs Deal Is A Wakeup Call For Apple Inc.?]

Google+, the new social networking service of Google Inc. (Nasdaq: GOOG) drew about 25 million visitors in less than a month, outpacing rivals Facebook Inc. and MySpace in their introductory days. Shares of Google fell 2.37 percent or $14.37 to close at $592.40.

RPX Corp. (Nasdaq: RPXC) reported 78 percent increase in its fiscal 2011 second quarter total revenue to $38.9 million. During the quarter, the leading provider of patent risk solutions registered GAAP net income of $7.7 million or 16 cents per diluted share on a pro forma basis. Shares were down 2.52 percent or 66 cents to close at $25.48.

Mednax Inc. (NYSE: MD) announced 13 percent growth in its fiscal 2011 Q2 net income to $55.9 million, or $1.15 per share, from $49.4 million or $1.04 per share a year earlier. During the period, the company's total revenue rose nearly 13 percent to $393.4 million from $349.1 million.


Next Page >>12
iOnTheMarket Premium
Advertisement

Advertisement


Comments Closed


rss feed

Latest Stories

article imageThe Sixty Percent Alibaba Play No One Is Talking About

It's official: Chinese e-commerce juggernaut Alibaba (NYSE: BABA) goes down as the biggest U.S. IPO in read on...

article imageThe Finer Points Of Hedging… Or Not

Barry Ritholtz asks the right question—Why hedge?–in the wake of last week’s announcement that California read on...

article imageBulls Leverage Hopeful News to Launch a Tepid Breakout Attempt

Stocks were able to leverage some optimistic news and dovish words from the Fed to take another stab at an read on...

article imageG-20 Minus One Country Plus 900 Bullet Points Equal 2 Percentage Points of Extra Growth?

For investors, the G-20’s super-secret plan to make the world grow faster is more a sideshow than a reason read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.